RESULTS	The Kaplan-Meier analysis of time to first recurrence during the follow-up period ( median time , 254 days [ range , 60 to 710 ] ) also showed that patients treated with irbesartan had a greater probability of remaining free of atrial fibrillation ( 79.52 % versus 55.91 % , P = 0.007 ) .\